Using the Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) to classify morphea by severity and identify clinically significant change.
CONCLUSIONS: The LoSCAT can be used to classify morphea patients by disease severity and identify clinically significant improvement in activity. This article is protected by copyright. All rights reserved.
PMID: 31049928 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - Category: Dermatology Authors: Teske NM, Jacobe HT Tags: Br J Dermatol Source Type: research